https://scholars.lib.ntu.edu.tw/handle/123456789/487254| Title: | Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial | Authors: | Kato K. Cho B.C. Takahashi M. Okada M. Lin C.-Y. Chin K. Kadowaki S. Ahn M.-J. Hamamoto Y. Doki Y. Yen C.-C. Kubota Y. Kim S.-B. CHIH-HUNG HSU Holtved E. Xynos I. Kodani M. Kitagawa Y. |
Issue Date: | 2019 | Publisher: | Lancet Publishing Group | Journal Volume: | 20 | Journal Issue: | 11 | Start page/Pages: | 1506-1517 | Source: | The Lancet Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074091428&doi=10.1016%2fS1470-2045%2819%2930626-6&partnerID=40&md5=1fc8f96f591304091c2afe4ce3437272 https://scholars.lib.ntu.edu.tw/handle/123456789/487254 |
ISSN: | 1470-2045 | DOI: | 10.1016/S1470-2045(19)30626-6 |
| Appears in Collections: | 腫瘤醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.